Appendix

EQS-News: NOTICE TO CONVENE MULTITUDE SE’S ANNUAL GENERAL MEETING OF SHAREHOLDERS

Retrieved on: 
Wednesday, April 10, 2024

The Board of Directors proposes to the Annual General Meeting that, for the financial year 2023, a dividend of EUR 0.19 per share be distributed.

Key Points: 
  • The Board of Directors proposes to the Annual General Meeting that, for the financial year 2023, a dividend of EUR 0.19 per share be distributed.
  • Shareholders, who are registered in the shareholders’ register of the Company, and who wish to participate in the General Meeting, must register for the meeting by giving prior notice of participation as instructed below.
  • Shareholders may participate in the General Meeting of Shareholders and exercise their rights at the meeting by way of proxy representation.
  • On the date of this notice to the Annual General Meeting of Shareholders, dated 28 March 2024, the total number of shares in Multitude SE is 21,723,960 and each of these shares carries one vote.

Caledonia Mining Corporation Plc: Non-Executive Director Changes

Retrieved on: 
Monday, March 18, 2024

ST HELIER, Jersey, March 18, 2024 (GLOBE NEWSWIRE) -- Caledonia Mining Corporation Plc ("Caledonia" or the "Company") (NYSE AMERICAN: CMCL; AIM: CMCL; VFEX: CMCL) is pleased to announce that Tariro Gadzikwa has joined Caledonia’s Board of Directors as an Independent Non-Executive Director with effect from March 15, 2024.

Key Points: 
  • ST HELIER, Jersey, March 18, 2024 (GLOBE NEWSWIRE) -- Caledonia Mining Corporation Plc ("Caledonia" or the "Company") (NYSE AMERICAN: CMCL; AIM: CMCL; VFEX: CMCL) is pleased to announce that Tariro Gadzikwa has joined Caledonia’s Board of Directors as an Independent Non-Executive Director with effect from March 15, 2024.
  • He will therefore leave the Board with effect from the next annual general meeting of the Company.
  • She has significant board experience and particular expertise in audit, risk management, corporate finance and finance strategy development.
  • As a Zimbabwean national based in Johannesburg, Tariro will add further depth to the Board’s considerable experience in Southern Africa.

GE Aerospace Launches as Independent, Investment-Grade Public Company Following Completion of GE Vernova Spin-Off

Retrieved on: 
Tuesday, April 2, 2024

GE Aerospace (NYSE: GE) today announced its official launch as an independent public company defining the future of flight, following the completion of the GE Vernova spin-off.

Key Points: 
  • GE Aerospace (NYSE: GE) today announced its official launch as an independent public company defining the future of flight, following the completion of the GE Vernova spin-off.
  • GE Aerospace will trade on the New York Stock Exchange (NYSE) under the ticker “GE”.
  • ET, GE Aerospace and GE Vernova will ring the opening bell together at the NYSE.
  • GE Aerospace Chairman and CEO H. Lawrence Culp Jr., said, “With the successful launch of three independent, public companies now complete – today marks a historic final step in the multi-year transformation of GE.

UPS Announces Strategic Initiatives And Three-Year Financial Targets

Retrieved on: 
Tuesday, March 26, 2024

At the conference, the company will share details of its strategic growth and productivity initiatives and discuss its three-year financial targets.

Key Points: 
  • At the conference, the company will share details of its strategic growth and productivity initiatives and discuss its three-year financial targets.
  • During the conference, UPS will highlight several strategic initiatives that will enable market share capture and expand its addressable market to drive incremental growth.
  • Today the company will discuss its 2026 financial targets as follows:
    Consolidated revenue ranging from approximately $108 billion to approximately $114 billion.
  • See the appendix to this release for a discussion of non-GAAP financial measures.

Secure Trust Bank PLC Preliminary Results for the 12 months to 31 December 2023

Retrieved on: 
Thursday, March 21, 2024

Secure Trust Bank PLC (‘STB’ or the ‘Group’), a leading specialist lender, is pleased to announce its financial results for the 12 months to 31 December 2023.

Key Points: 
  • Secure Trust Bank PLC (‘STB’ or the ‘Group’), a leading specialist lender, is pleased to announce its financial results for the 12 months to 31 December 2023.
  • The Group has made good progress on its Optimising for Growth strategic priorities to drive sustainable and attractive RoAE.
  • Statutory cost income ratio at 57.5% (2022: 55.0%)
    Cost of risk stable at 1.4% (2022: 1.4%)
    "Secure Trust has made significant progress in 2023 against our strategic priorities.
  • Once again, we have demonstrated our ability to grow in 2023 and the Group is well placed to realise our ambitions.

CareMax Reports Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Monday, March 18, 2024

CareMax, Inc. (NASDAQ: CMAX; CMAXW) (“CareMax” or the “Company”), a leading technology-enabled value-based care delivery system, today announced financial results for the fourth quarter and full year ended December 31, 2023.

Key Points: 
  • CareMax, Inc. (NASDAQ: CMAX; CMAXW) (“CareMax” or the “Company”), a leading technology-enabled value-based care delivery system, today announced financial results for the fourth quarter and full year ended December 31, 2023.
  • “In the fourth quarter, we began taking major steps with the goal of solidifying the long-term viability of our business,” said Carlos de Solo, Chief Executive Officer.
  • Having achieved a 5-Star quality rating across our centers for the third consecutive year, CareMax remains at the forefront of enabling physicians to succeed under value-based care.
  • Adjusted EBITDA was ($71.8) million, compared to $4.5 million for the fourth quarter of 2022.1
    Platform Contribution was ($55.6) million, compared to $25.6 million for the fourth quarter of 2022.1
    Medical Expense Ratio was 122.7%, compared to 69.5% for the fourth quarter of 2022, primarily due to the impacts of prior period developments and a provision for adverse deviation.

India Beer and Cider Analysis Report 2023 Featuring United Breweries, A-BInBev, Carlsberg, B9 Beverages, and Som Distilleries & Breweries - ResearchAndMarkets.com

Retrieved on: 
Monday, March 11, 2024

The "India Beer and Cider Analysis by Category and Segment, Company and Brand, Price, Distribution, Packaging and Consumer Insights" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "India Beer and Cider Analysis by Category and Segment, Company and Brand, Price, Distribution, Packaging and Consumer Insights" report has been added to ResearchAndMarkets.com's offering.
  • Beer and Cider Market Insights report provides detailed data and textual analysis of the beer and cider sector and the report contains introduction, category and segment insights, company and brand insights, distribution insights, packaging insights, consumer insights, recommendations and appendix sections.
  • Amid rising inflation, low-income Indians reduced their beer consumption frequency or switched from hard liquor or spirits to drinks with a higher alcohol content.
  • Analyze domestic and imported beer brand performance and determine the key trends driving consumption preference to develop a competitive advantage.

Notice - CAPITAL MARKETS TRIBUNAL ANNOUNCES AMENDMENTS TO ITS RULES OF PROCEDURE

Retrieved on: 
Tuesday, March 19, 2024

TORONTO, March 19, 2024 /CNW/ - On March 19, 2024, the Capital Markets Tribunal implemented substantial amendments to its Rules of Procedure (Rules).

Key Points: 
  • TORONTO, March 19, 2024 /CNW/ - On March 19, 2024, the Capital Markets Tribunal implemented substantial amendments to its Rules of Procedure (Rules).
  • The former Rules of Procedure and Forms and Practice Guideline are repealed in their entirety and replaced by the new Rules, which are effective immediately.
  • The Rules apply to all Tribunal proceedings, including proceedings commenced prior to the issuance of this Notice.
  • In addition, the amendments to the Rules improve readability, clarify requirements, and will improve the efficiency of Tribunal proceedings.

Union procedure on the preparation, conduct and reporting of EU pharmacovigilance inspections

Retrieved on: 
Wednesday, April 3, 2024

Union procedure on the preparation, conduct and

Key Points: 
    • Union procedure on the preparation, conduct and
      reporting of EU pharmacovigilance inspections
      Table of contents
      1.
    • Record management and archiving ....................................................................... 12

      References ................................................................................................ 12
      Appendix 1 ?Pharmacovigilance inspection report .................................... 13
      Appendix 2- Inspection overview (IO) ...................................................... 14
      Appendix 3- Pharmacovigilance inspection outcome sharing .................... 15
      Appendix 4- Classification of inspection findings....................................... 16

      Union procedure on the preparation, conduct and reporting of EU pharmacovigilance
      inspections
      EMA/INS/PhV/192230/2014

      Page 2/16

      1.

    • Guidelines on the interpretation of legislative pharmacovigilance
      requirements are published in the adopted good pharmacovigilance practices (GVPs) Module III ?
      pharmacovigilance inspections.
    • Preparation of a risk-based programme for pharmacovigilance inspections is presented in the Union
      procedure on the coordination of EU pharmacovigilance inspections.
    • Scope
      This procedure constitutes a guideline in preparing, conducting and reporting national competent
      authority (NCA) pharmacovigilance inspections and outlines the steps taken of the Committee for
      Medicinal Products for Human Use (CHMP) requested pharmacovigilance inspections.
    • Those are covered under the Union procedure on the
      management of pharmacovigilance inspection findings which may impact the robustness of the benefitrisk profile of the concerned medicinal products.
    • Union procedure on the preparation, conduct and reporting of EU pharmacovigilance
      inspections
      EMA/INS/PhV/192230/2014

      Page 3/16

      3.

    • Preparation
      Preparation encompasses those activities undertaken after the selection of an MAH, or third party, for
      a pharmacovigilance inspection and prior to inspection conduct.
    • For the selection of involved
      parties for CHMP requested inspections, refer to the Union procedure on the coordination of EU
      pharmacovigilance inspections.
    • Announcement communications could include, for example, the

      Union procedure on the preparation, conduct and reporting of EU pharmacovigilance
      inspections
      EMA/INS/PhV/192230/2014

      Page 4/16

      name of the inspector(s), MAH, the objectives and nature of the inspection (i.e.

    • Union procedure on the preparation, conduct and reporting of EU pharmacovigilance
      inspections
      EMA/INS/PhV/192230/2014

      Page 5/16

      ?

      Feedback from other competent authority functions, in particular pharmacovigilance assessors.

    • Union procedure on the preparation, conduct and reporting of EU pharmacovigilance
      inspections
      EMA/INS/PhV/192230/2014

      Page 6/16

      ?

      If teleconference(s) are planned during the inspection with experts, assessors, MAH personnel
      located off site etc.

    • ?

      Union procedure on the management of pharmacovigilance inspection findings which may impact
      the robustness of the benefit-risk profile of the concerned medicinal products.

    • Union procedure on the preparation, conduct and reporting of EU pharmacovigilance
      inspections
      EMA/INS/PhV/192230/2014

      Page 12/16

      Appendix 1 ?Pharmacovigilance inspection report
      Click here for the template.

    • Union procedure on the preparation, conduct and reporting of EU pharmacovigilance
      inspections
      EMA/INS/PhV/192230/2014

      Page 13/16

      Appendix 2- Inspection overview (IO)
      Click here for the template.

    • Union procedure on the preparation, conduct and reporting of EU pharmacovigilance
      inspections
      EMA/INS/PhV/192230/2014

      Page 14/16

      Appendix 3- Pharmacovigilance inspection outcome sharing
      Click here for the template.

    • Union procedure on the preparation, conduct and reporting of EU pharmacovigilance
      inspections
      EMA/INS/PhV/192230/2014

      Page 16/16

Shocked to the core: a new model to understand euro area inflation

Retrieved on: 
Tuesday, April 2, 2024

The pandemic's disruption of global supply chains and the spike in natural gas prices following Russia’s invasion of Ukraine were significant drivers of surging inflation.

Key Points: 
  • The pandemic's disruption of global supply chains and the spike in natural gas prices following Russia’s invasion of Ukraine were significant drivers of surging inflation.
  • Traditional inflation models often ignore such supply-side shocks, even though they can have a significant and persistent impact on core inflation in the euro area (as measured by rates of change in the Harmonised Index of Consumer Prices excluding the energy and food components).